Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
Special Report by David Williams (EPSRC Center for Innovative Manufacturing in Regenerative Medicine, UK) where he and his team share their experiences in qualifying the Cell Therapy Manufacturing Facility, focusing on their approach to streamlining the qualification effort, the challenges, project delays and inefficiencies they encountered, and finally the subsequent lessons learned.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>